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Abstract: Background: The Golgi apparatus undergoes disorganization in response to stress, but it is
able to restore compact and perinuclear structure under recovery. This self-organization mechanism
is significant for cellular homeostasis, but remains mostly elusive, as does the role of giantin, the
largest Golgi matrix dimeric protein. Methods: In HeLa and different prostate cancer cells, we used
the model of cellular stress induced by Brefeldin A (BFA). The conformational structure of giantin was
assessed by proximity ligation assay and atomic force microscopy. The post-BFA distribution of Golgi
resident enzymes was examined by 3D SIM high-resolution microscopy. Results: We detected that
giantin is rather flexible than an extended coiled-coil dimer and BFA-induced Golgi disassembly was
associated with giantin monomerization. A fusion of the nascent Golgi membranes after BFA washout
is forced by giantin re-dimerization via disulfide bond in its luminal domain and assisted by Rab6a
GTPase. GM130-GRASP65-dependent enzymes are able to reach the nascent Golgi membranes, while
giantin-sensitive enzymes appeared at the Golgi after its complete recovery via direct interaction
of their cytoplasmic tail with N-terminus of giantin. Conclusion: Post-stress recovery of Golgi is
conducted by giantin dimer and Golgi proteins refill membranes according to their docking affiliation
rather than their intra-Golgi location.
Keywords: Brefeldin A; Golgi biogenesis; giantin; Rab6a; GRASP65
1. Introduction
The Golgi complex in one of the largest cellular organelles, which is increasingly viewed as
the main coordinator of different trafficking pathways and molecular events that play a grand role
in cellular homeostasis [1,2]. For years, researchers have obsessed over the molecular mechanisms
that contribute to Golgi function and unique ribbon-like architecture. The emerging consensus is
that the sequential distribution of enzymes in the interconnected stacks of flat cisternae provides the
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appropriate modifications to the cargo [3,4]. This is the main paradigm of secretory transport through
the Golgi, regardless of whether it is postulated by the cisternal or vesicular model [5,6]. Therefore,
the intact and perinuclear position of Golgi is ideal for the complete processing of proteins. However,
in response to different intracellular perturbations, including inhibition of endoplasmic reticulum
(ER) to Golgi trafficking and subsequent ER stress, as well as the treatment with or consumption
of various chemicals and alcohol, Golgi undergoes disorganization, characterized by unstacking its
membranes and abnormal glycosylation [7–13]. Nevertheless, Golgi has a phenomenal self-organizing
mechanism [14,15], and, under drug- or stress-free conditions, Golgi is able to return to its classical
ribbon-like structure and perinuclear positioning [16–19]. This fact is of particular note because, despite
over 100 years of Golgi research, scientists are still at a loss to explain the mechanisms of Golgi’s ability
to maintain and recover harmony in such complicated structure.
It has now been more than thirty years since fungal metabolite Brefeldin A (BFA) was employed as
a model for the effective blockade of ER-to-Golgi transportation and rapid Golgi disorganization [20].
BFA-induced Golgi disassembly is reversed upon drug washout (WO) [16,17], and BFA acts as an
uncompetitive inhibitor that binds to the Arf1–GDP–GEF complex, thus blocking the activation of
ARF1 and subsequent COPI coat assembly [21–23]. Indeed, loss of COPI vesicles from the Golgi is
one of the earliest responses to BFA treatment [24]. However, knockdown (KD) of COPI coatomer
proteins, including β-COP, despite Golgi disorganization, does not mimic the crucial effect of BFA, i.e.,
collapse of Golgi membranes and their absorption into the ER [25–29]. This suggests that BFA is the
drug having the potential to perform multiple tasks, especially in that it may have an effect on the
structure of Golgi scaffold proteins.
The integrity of the Golgi requires structural cooperation of its matrix (golgins) and residential
proteins [30–32]; in turn, Golgi compact organization is likely to be a paramount condition for the
successful trafficking of some critical enzymes to the Golgi [33,34]. While enzymes are responsible
for the processing of proteins, golgins serve as the guardians of Golgi’s monolithic architecture and
docking sites for many Golgi targeting vesicles [35–39]. The function of golgins is coordinated by Golgi
reassembly stacking proteins (GRASPs) [40–42]. We recently identified that Golgi glycosyltransferases
employ two different recruiting sites at the Golgi: giantin and the complex of GM130 and GRASP65 [43].
Giantin is the largest (376 kDa) Golgi matrix protein. It has a long (≥350 kDa) cytoplasmic N-terminal
region followed by one-pass trans-membrane domain and short Golgi lumenal C-terminal domain
which stabilizes dimeric giantin via a disulfide bond [44,45]. It has been suggested that giantin could be
essential in the cross-bridge structures that maintain Golgi morphology and it is required for efficient
SNARE-mediated fusion [44,46]; however, this has never been directly tested. A strong argument
in defense of this hypothesis came from a study showing that, during apoptosis, giantin is more
stably associated with Golgi fragments than other golgins [47,48]. In addition, the Warren group,
using a microsurgery approach, developed Golgi-free cytoplasts from large African green monkey
cells [49], and these cells failed in de novo Golgi biogenesis. However, when cells were treated with
BFA, followed by microsurgery, even a small amount of giantin in the cytoplast was sufficient to
restore Golgi membranes. In addition, it was recently shown that depletion of giantin resulted in more
dispersed Golgi stacks after treatment with Nocodazole, a microtubule depolymerization agent [50].
Thus, it appears that giantin is the core Golgi protein that drives Golgi biogenesis, but the underlying
mechanism remained enigmatic.
Recently, we revealed that ethanol (EtOH) treatment blocks activation of SAR1A GTPase, thus
preventing COPII vesicle-mediated Golgi targeting of protein disulfide isomerase A3 (PDIA3),
the chaperone that catalyzes dimerization of giantin [13,34]. In EtOH-treated hepatocytes,
Golgi is consequently disorganized and Golgi targeting of mannosyl (α-1,3-)-glycoprotein
beta-1,2-N-acetylglucosaminyltransferase (MGAT1), the key enzyme of N-glycosylation, is altered [51].
In addition, we previously showed that giantin determines Golgi localization for core 2 O-glycosylation
enzymes (both N-acetylglucosaminyltransferase 2/M and 1/L, C2GnT-M and C2GnT-L) [34,43], and
glycogen synthase kinase β (GSK3β) [52]. Moreover, we recently found that EtOH-induced Golgi
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disorganization in prostate cancer (PCa) cells is accompanied by mislocalization of the N-glycosylation
enzyme, N-acetylglucosaminyltransferase-III (MGAT3), again implying its sensitivity to giantin [53].
Thus, different classes of Golgi residential enzymes seem giantin-dependent: recent observation in the
giantin knockout model reveals another Golgi protein, N-acetylgalactosaminyltransferase 3 (GALNT3),
which is down-regulated in cells lacking giantin [54]. In addition, the siRNA-mediated KD of giantin
results in an abnormal rate and glycosylation of some plasma membrane (PM)-associated anterograde
cargo [50]. Importantly, we also recently reported that giantin is required for post-alcohol recovery of
Golgi in liver cells and PM-directed trafficking of important hepatic proteins [55].
Here, using different approaches, we found that BFA-induced Golgi disorganization is associated
with the monomerization of giantin. In cells recovering from BFA, giantin, but not other golgins and
GRASPs, is the key protein responsible for the restoration of juxtanuclear and flattened Golgi. The
fusion of the nascent Golgi membranes is assisted by Rab6a GTPase. The ability to assess a Golgi
3D-structure using high-resolution microscopy enabled us to discover the sequential Golgi targeting of
residential enzymes: giantin-independent proteins filled Golgi membranes during recovery, while
giantin-sensitive did so only after a complete restoration of stacks. Finally, we found that giantin is
involved in the formation of “long” intercisternal communications.
2. Material and Methods
2.1. Antibodies and Reagents
The primary antibodies used were: (a) rabbit polyclonal—giantin (Novus Biologicals, Centennial,
CO, USA, NBP2-22321), giantin (Abcam, Cambridge, UK, ab24586 and ab93281), NMIIA (Abcam,
ab75590), and GST (Abcam, ab19256); (b) rabbit monoclonal—SAR1B (Abcam, ab155278), GAPDH
(Cell Signaling Technology, Danvers, MA, USA, 14C10), Man-I (Abcam, ab140613), MGAT1 (Abcam,
ab180578), GM130 (Abcam, ab52649), GRASP65 (Abcam, ab174834); (c) mouse monoclonal—HSP70
(Abcam, ab2787), NMIIB (Abcam, ab684), GRASP65 (Santa Cruz Biotechnology, Dallas, TX, USA,
sc365434), β-actin (Sigma-Aldrich, St. Louis, MO, USA, A2228), giantin (Abcam, ab37266), SAR1A
(Abcam, ab77029), Rab6a (Santa Cruz Biotechnology, sc-81913); and (d) mouse polyclonal—MGAT1
(Abcam, ab167365), GM130 (Abcam, ab169276). The secondary antibodies (Jackson ImmunoResearch,
West Grove, PA, USA) were: (a) HRP-conjugated donkey anti-rabbit (711-035-152) and donkey
anti-mouse (715-035-151) for W-B; and (b) donkey anti-mouse Alexa Fluor 488 (715-545-150) and
anti-rabbit Alexa Fluor 594 (711-585-152) for immunofluorescence. Brefeldin A (EMD Chemicals,
Gibbstown, NJ, USA) and MG-132 (Frontier Scientific, Logan, UT, USA) were dissolved in DMSO
immediately before use. Brefeldin A was added to the cultured cells at a final concentration of 36
µM, which was followed by incubation at 37 ◦C for the 1 h. To study Golgi recovery after Brefeldin
A treatment, cells were rinsed at least 3 times with pre-warmed drug-free medium followed by
incubation under regular culture conditions for various durations as described in each experiment.
NEM (N-ethylmaleimide) was obtained from Thermo Scientific (Waltham, MA, USA), dissolved in
water and applied to the cell pellet in at 2 mM prior to the cell lysis buffer. All other chemicals and
reagents including methanol and DMSO were of MS-grade/analytical grade and purchased from Sigma.
2.2. Immunoprecipitation (IP), Plasmid Constructions and Transfection
For identification of proteins in the complexes pulled down by IP, confluent cells grown in a
T75 flask were washed three times with 6 mL PBS each, harvested by trypsinization, and neutralized
with soybean trypsin inhibitor at a 2× weight of trypsin. IP steps were performed using Pierce
Co-Immunoprecipitation Kit (Thermo Scientific) according to manufacturer instructions. Mouse and
rabbit non-specific IgG was used as non-specific controls. All cell lysate samples for IP experiments
were normalized by appropriate proteins. To determine whether the target protein was loaded evenly,
input samples were preliminarily run on a separate gel with different dilutions of control samples
vs. treated, and then probed with anti-target protein Abs. The intensity of obtained bands was
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analyzed by ImageJ software, and samples with identical intensity were subjected to IP. MYH9 (myosin,
heavy polypeptide 9, non-muscle, NMIIA), MYH10 (myosin, heavy polypeptide 10, non-muscle,
NMIIB), SAR1A, SAR1B, GOLGB1 (giantin), GOLGA2 (GM130), GORASP1 (GRASP65), Rab6a, and
scrambled on-targetplus smartpool siRNAs were purchased from Santa Cruz Biotechnology. All
products consisted of pools of three target-specific siRNAs. Cells were transfected with 100 nM siRNAs
using Lipofectamine RNAi MAX reagent (Life Technologies, Carlsbad, CA, USA). PCMV-intron myc
Rab6 T27N was a gift from Terry Hebert (Addgene, Cambridge, MA, USA, plasmid # 46782) [56].
Transient transfection of cells was carried out using Lipofectamine 3000 (Life Science technologies)
following manufacturer protocol. Rab6a–pCMV3–C–OFPSpark (RFP tag) was ordered from Sino
Biological. GOLGB1 (giantin)–pCMV6–AC–GFP plasmids were obtained from OriGene.
The Cys3254Ser substitution in giantin protein was performed using the standard cloning
and PCR-mediated site-directed mutagenesis (SDM) procedures. Given that the original plasmid
GOLGB1 (giantin)–pCMV6–AC–GFP is too big for amplification (16 kb), we generated a smaller
(8 kb) substrate for SDM as follows: 4 kb C-terminal fragment of the GOLGB1 from the GOLGB1
(giantin)–pCMV6–AC–GFP was subcloned into pET28b vector within EcoRV and NotI restriction sites.
Then resulting plasmid pET28b-GOLGB1-C-terminus was amplified with mutagenic overlapping
primers: Ser3254F (5′-GCTCATTCTGTCTTTTACGGGCCATCTAACGCGTACGCGG) and Ser3254R
(5′-CCGTAAAAGACAGAATGAGCAGGACATGAATCATTAGAAAGTAGATGGCTGC). For SDM
PCR we used Phusion High-Fidelity DNA Polymerase (Thermo Scientific) and cycler program: 95 ◦C
2′ + 15 × [95 ◦C 30” + 60 ◦C 1′ + 72 ◦C (12′ + 6”)] + 72 ◦C 6′. After PCR completion, the PCR reaction
mixture was treated with DpnI restriction enzyme (to digest methylated template) and then used to
transform E. coli TOP10 strain. A positive clone was confirmed by restriction analysis and Sanger
sequencing. Then, mutated plasmid was digested with EcoRV, NotI, and PvuI restriction enzymes.
PvuI was used to cut pET28b backbone which has same (4 kb) size as subcloned C-terminus of the
GOLGB1. A 4 kb EcoRV NotI fragment of the pET28b-GOLGB1-C-terminus-MUT was ligated with
12 kb EcoRV NotI fragment of the GOLGB1 (giantin)–pCMV6–AC–GFP. Positive clones were selected
by restriction analysis and sequencing.
2.3. In Vitro Crosslinking
The protocol of crosslinking was followed according to the manufacturer’s (Thermo Scientific)
instructions. Briefly, PBS-washed (three times) microsomal fraction of cells were exposed to 0.2 mM
dithiobis (sulfosuccinimidylpropionate) (DTSSP) in water for 30 min at room temperature. Cross-linked
protein was analyzed by SDS-PAGE under non-reducing conditions since the DTSSP cross-linker
is thiol-cleavable.
2.4. Confocal Immunofluorescence Microscopy
The staining of cells was performed by methods described previously [29]. Slides were examined
under a Zeiss 510 Meta Confocal Laser Scanning Microscope and LSM 800 Zeiss Airyscan Microscope
(Carl Zeiss Microscopy, Jena, Germany) performed at the Advanced Microscopy Core Facility of the
University of Nebraska Medical Center. Fluorescence was detected with fixed exposure time, using an
emission filter of a 505–550 nm band pass for green, and a 575–615 nm band pass for red. Images were
analyzed using ZEN 2.3 SP1 software. For some figures, image analysis was performed using Adobe
Photoshop and ImageJ. Statistical analysis of colocalization was performed by ImageJ, calculating the
Pearson correlation coefficient [57].
2.5. Three-Dimensional Structured Illumination (3D-SIM) Microscopy and Image Analysis
SIM imaging of Golgi ribbons was performed on a Zeiss ELYRA PS.1 super-resolution scope (Carl
Zeiss Microscopy) using a PCO.Edge 5.5 camera equipped with a Plan-Apochromat 63× 1.4 oil objective.
Optimal grid sizes for each wavelength were chosen according to manufacturer recommendations.
For 3D-SIM, stacks with a step size of 110 nm were acquired sequentially for each fluorophore, and
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each fluorescent channel was imaged with three pattern rotations with three translational shifts. The
final SIM image was created using modules built into the Zen Black software suite accompanying
the imaging setup. Analyses were undertaken on 3D-SIM datasets in 3D using IMARIS versions
7.2.2–7.6.0 (Bitplane AG, Zurich, Switzerland). The calculation of intercisternal distances was based on
nearest neighbor distances to consider the Nyquist limited resolution, which in our case was around
~94 nm [58]. The 3D mask was obtained by applying a Gaussian filter to merged channels, thresholding
to remove low-intensity signals, and converting the obtained stack into a binary file that mapped all
voxels of interest for coefficient calculation. For colocalization studies, IMARIS “Colocalization Module”
was used. To avoid subjectivity, all thresholds were automatically determined using algorithms based
on the exclusion of intensity pairs that exhibit no correlation [59]. Colocalization was determined
by Pearson’s coefficient, which represents a correlation of channels inside colocalized regions. After
calculation, colocalization pixels were displayed as white. 3D animation was generated using IMARIS
“Animation Module”.
2.6. AFM Imaging and Image Analysis
Giantin-GFP was isolated from DMSO and BFA-treated cells using GFP-Trap Magnetic Agarose
(ChromoTek, Planegg, Germany) according to the manufacturer’s recommendations. Eluted IP samples
were isolated using Millipore UFC500324 Amicon Ultra Centrifugal Filters and then dissolved in PBS
for pH neutralization. Next, about 10 µL samples were treated with 2% of β-mercaptoethanol and
deposited onto a piece of freshly cleaved mica. After 2 min incubation samples were rinsed briefly
with several drops of deionized water and dried with a gentle flow of argon. Images were collected
with MultiMode Nanoscope IV system (Bruker Instruments, Santa Barbara, CA, USA) in Tapping
Mode at ambient conditions. Silicon probes RTESPA-300 (Bruker Nano Inc., Billerica, MA, USA) with a
resonance frequency of ~300 kHz and a spring constant of ~40 N/m were used for imaging at scanning
rate for about 2.0 Hz. Images were processed using the FemtoScanOnline software package (Advanced
Technologies Center, Moscow, Russia).
2.7. In Situ Proximity Ligation Assay
The assay was performed using the Duolink kit (Sigma-Aldrich) according to the manufacturer’s
protocol. The mouse monoclonal anti-giantin Ab, which recognizes the cytoplasmic N-terminus
(3–91 aa) (Sigma, WH0002804M1) was used in combinations with: (a) rabbit polyclonal, which is raised
against the central region of giantin (1781–1907 aa) (Sigma, HPA011008); and (b) rabbit polyclonal to
giantin (region within N terminal 108–157 aa, Abcam ab93281). After incubation with primary Abs,
cells were incubated with oligonucleotide-conjugated anti-mouse minus and anti-rabbit plus proximity
ligation assay secondary probes. Subsequent PLA signal was detected by confocal microscopy and the
corrected integrated fluorescence intensity was calculated using the ImageJ software.
2.8. Isolation of Golgi Membrane Fractions by Sucrose Gradient Centrifugation
Golgi membrane fractions were isolated using methods described previously [29]. Cells from
ten-to-twelve 75 cm2 cell culture flasks were harvested with PBS containing 0.5× protease inhibitors
(1.2 mL per flask). Then, after centrifugation for 5 min at 1000 rpm and 4 ◦C, the pellet was resuspended
in 3 mL of homogenization buffer (0.25 M sucrose, 3 mM imidazole, 1 mM Tris-HCl; pH7.4, 1 mM
EDTA). Cells were homogenized by drawing ~ 30 times through a 25-gauge needle until the ratio
between unbroken cells and free nuclei became 20%:80%. The postnuclear supernatant was obtained
by centrifugation at 2500 rpm and 4 ◦C for 3 min, and then, the supernatant was adjusted to 1.4 M
sucrose by addition of ice-cold 2.3 M sucrose in 10 mM Tris-HCl (pH 7.4). Next, 1.2 mL of 2.3 M
sucrose at the bottom of the tube was overlaid with 1.2 mL of the supernatant adjusted to 1.4 M sucrose
followed by sequential overlay with 1.2 mL of 1.2 M and 0.5 mL of 0.8 M sucrose (10 mM Tris-HCl,
pH 7.4). Gradients were centrifuged for 3 h at 38,000 rpm (4 ◦C) in an SW40 rotor (Beckman Coulter,
Brea, CA, USA). The turbid band at the 0.8 M/1.2 M sucrose interface containing Golgi membranes
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was harvested in ~500 µL aliquot by syringe puncture. The fraction at a concentration of ~1.0–1.4 mg
protein/mL was used for the experiments mentioned in the Section 3.
2.9. Zonal Sedimentation Analysis on Sucrose Gradients
Dimeric and monomeric giantin was analyzed by ultracentrifugation on layered 5–25% (wt/vol)
sucrose gradients (9 mL) with a 2-mL 60% sucrose cushion prepared in 50 mM Tris-HCl (pH 7.5) and
100 mM NaCl. Isolated Golgi fractions were loaded on the top of separate sucrose gradients and
centrifuged in an SW41 rotor (Beckman Coulter Inc., Fullerton, CA, USA) at 35,000 rpm for 16 h at
4 ◦C. Fractions of 0.25 mL were collected from the top of the tube and analyzed by immunoblotting
with giantin Ab. As high molecular weight standard protein, we used an 800 kDa protein Nesprin,
for which the specific band on SDS-PAGE was used for consideration of the size of giantin dimer.
Densitometric analysis of the obtained band was performed using the ImageJ software.
2.10. Isolation of Microsomal Fraction
Isolation of microsomes was performed using Endoplasmic Reticulum Isolation Kit (Sigma)
according to the manufacture’s protocol. Briefly, cells were suspended in Hypotonic Extraction Buffer
and incubated for 20 min at 4 ◦C to allow the cells to swell. Then, after centrifugation at 600× g
for 5 min and homogenization, the homogenate was centrifuged at 1000× g for 10 min (4 ◦C). The
obtained postnuclear supernatant was centrifuged at 12,000× g for 15 min (4 ◦C), and supernatant
(post mitochondrial fraction) was further subjected to isolation of rough endoplasmic reticulum (RER)
using precipitation by 8 mM CaCl2.
2.11. Statistical Analysis
Measurements for the giantin KD do not follow a normal distribution as detected via the
Lilliefors test at p ≤ 0.05 [60]; hence, hypothesis testing for different medians was performed via the
non-parametric Wilcoxon rank sum test [61] for control versus giantin KD for the three parameters:
cisternal length, intercisternal distance, and number of intercisternal connections. Data are expressed
as mean ± SD. The rest of the analysis was performed using the two-sided t-test. A value of p < 0.05
was considered statistically significant.
2.12. Miscellaneous
Protein concentrations were determined with the Coomassie Plus Protein Assay (Pierce Chemical
Co., Rockford, IL, USA) using BSA as the standard. Densitometric analysis of band intensity was
performed using ImageJ.
3. Results
3.1. BFA-induced Golgi Disorganization Is Associated with Giantin Monomerization
Given that giantin de-dimerization was detected in EtOH-treated cells, as well as in PCa cells
with fragmented Golgi phenotype [13,34], we hypothesized that the ER stress, induced by BFA, is also
accompanied by giantin monomerization. We tested this possibility in HeLa cells treated with 36 µM
BFA for 1 h, only because prolonged (up to 3 h) treatment with BFA is known to launch apoptosis, as
indicated by the enhanced expression of caspase-3 (Figure S1A), membrane blebbing, and chromatin
condensation (Movie S1) [62,63]. As predicted, 1-h treatment with BFA induces Golgi membrane
dissolution into the cytoplasm (Movie S2). Using sucrose gradient (5–20%) sedimentation analysis of
Golgi fraction, we found that, in the 25% fraction from DMSO-treated cells, the giantin-specific signal
appeared as double bands: with upper band corresponding to the 800 kDa (giantin dimer) and lower
band around 400 kDa (giantin monomer) (Figure 1A). However, in BFA-treated cells, the portion of
dimeric giantin was significantly reduced. Predictably, in 5% sucrose fraction, little if any dimeric
giantin was detected in both DMSO- and BFA-treated samples. On the other hand, dimerization
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of giantin seems dispensable for its Golgi localization, as we were able to detect a large fraction
of monomeric giantin in the Golgi remnants. Our data fit well with the previous observation that
postulates the Golgi retention domain of giantin resides within its C-terminal sequence adjacent to
the membrane-anchoring domain (positions 3059–3161 aa), but not within the luminal domain where
disulfide bond is formed [64].
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Figure 1. Gianti dimerization in Brefel (BFA) and BFA-washout (WO) cells. (A) H La c lls were
treated with 36 µM BFA for 1 h or with a corresponding amount of DMSO (contr l). The Golgi fractions
isolated from cells were subjected to sucrose sedimentation analysis on a 5–25% sucrose gradient. The
25% and 5% fractions were collected and analyzed by 4–15% SDS-PAGE. The samples were prepared
under low (1%) concentrations of β-mercaptoethanol, and the same amount of proteins were loaded.
Giantin-dimer and monomer are indicated by arrows. The size marker indicates 800 kDa protein
Nesprin, which corresponds to the giantin dimer. Densitometry analysis of ratio monomer/dimer
is presented below. (B) Giantin W-B of the lysates of HeLa cells treated with DMSO and BFA for
1 h. The lysates were prepared in the presence (+) or absence (−) of 2 mM NEM followed by 1%
β-mercaptoethanol and resolved by 8% SDS-PAGE. (C) Giantin W-B of the lysates of HeLa cells treated
with DMSO, BFA f r 1 h, and BFA-WO for ther 60 min. The lysates were prepared u der 2 mM
NEM followed by 5% β-mercaptoeth nol and resolv d by 10% SDS-PAGE. Botto panel: β-actin as a
loading control. (D) Quantification of the band’s intensity mono er/dimer from three independent
experiments presented in (C). Data are presented as a mean ± SD; * p < 0.001. (E) Giantin W-B of the
lysates of HeLa cells: DMSO, BFA, and BFA-WO. Samples were prepared under 2 mM NEM followed
by 20 mM DTT and run on 10% SDS-PAGE. (F) Giantin W-B of the lysates of HeLa cells: DMSO, BFA,
and treated with 5 µM MG-132 for 3 h followed by BFA. Samples were prepared under 2 mM NEM
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followed by 10% β-mercaptoethanol and run on 10% SDS-PAGE; β-actin was a loading control. The
data are representative from three independent experiments. (G) Top panel: Giantin and GM130
W-B of the ER (microsomal) fraction isolated from HeLa cells: DMSO, BFA, and BFA-WO for 30 min.
Samples were prepared under 2 mM NEM followed by 10% β-mercaptoethanol and run on 4–15%
SDS-PAGE; HSP70 was a loading control. Densitometry analysis of ratio giantin/HSP70 is presented
below. The data are representative from three independent experiments. Bottom panel: GM130 W-B of
the Golgi fractions isolated from the cells presented in the top panel. (H) Giantin W-B of the microsomal
fractions of HeLa cells incubated in presence of 2 mM DTSSP at RT. Samples were prepared under
non-reducing conditions to avoid cleavage of thiol groups and run on 4–15% SDS-PAGE; HSP70 was a
loading control.
Next, we performed a series of SDS-PAGE, using the cell lysate samples prepared under different
reducing conditions. Prior to lysis, samples were pretreated with 2 mM N-ethylmaleimide (NEM),
which blocks free sulfhydryls. Indeed, as shown in Figure 1B, post-lysis dimerization of giantin was
prevented in presence of NEM, especially in BFA-treated samples, which, however, is restored at the
60 min of BFA-WO (Figure 1C,D), again indicating that BFA induces de-dimerization of giantin. Of
note, the level of giantin-dimer was positively correlated with the restoration of Golgi perinuclear
positioning and was identical to untreated cells after 60 min of WO (data not shown). This raises
the possibility that giantin dimerization occurs during Golgi de novo formation. Next, in samples
prepared under 20 mM DTT, another strong reducing agent, the dimer-specific band was not detected
at all, confirming that the dimerization of giantin is mediated by a disulfide bond [44,45] (Figure 1E).
We previously detected that in Panc-1 cells expressing C2GnT-M tagged with c-Myc, BFA
treatment not only induces the redistribution of C2GnT-M to the ER, but also reduces its level via
proteasome-mediated degradation [65], echoing observations of other groups [66,67]. In addition,
it has been reported that upon BFA treatment the content of most Golgi matrix proteins, including
giantin, may also be reduced [68]. Thus, one may assume that the loss of giantin dimer is rather a
consequence of its proteasome-mediated degradation than unwinding of its dimeric structure [69].
Here, at this BFA dosage and timing, we could not detect a significant reduction in the giantin content
but, to check this possibility, prior to BFA treatment, we pretreated cells with the proteasome inhibitor
MG-132. Importantly, as we have shown before, MG-132 does not block the disorganization effect of
BFA on Golgi [29]. Here, we observed that the effect of BFA on giantin in cells pretreated with MG-132
appears identical to cells treated with BFA only (Figure 1F). The data indicate that de-dimerization of
giantin by BFA cannot be attributed to its degradation. Further, we performed experiments using a
lower dosage of BFA (18 µM for 2 h or 3.6 µM for 10 h) and the results were identical: in both cases,
Golgi disorganization was associated with giantin monomerization (Figure S1B–E). However, at the
720 nM dosage, we could not detect the disorganization effect of BFA (Figure S1F).
The initial inference that BFA induces separation of resident Golgi proteins from matrix Golgi
proteins [16,70,71] was revisited after findings indicating that glycosyltransferases and golgins were
in the same tubular structures emanating from the Golgi and ER-localized BFA remnants [15,32,36].
However, giantin was partially detected in the ER, while some other matrix proteins, including GM130,
were retained in these small tubulovesicular profiles [32]. Here, in the microsomal fraction isolated
from BFA-treated cells, we were able to detect only monomeric giantin, and predictably, no visible
signal of GM130 was detected (Figure 1G). Further, we could not find any pieces of evidence indicating
that BFA affects di- or oligomerization of both GRASP65 or GM130 (Figure S2). Finally, a post-BFA
ER/microsomal fraction of cells were incubated in 1 mM DTSSP, a cross-linker. As shown in Figure 1H,
in presence of DTSSP, the giantin-specific signal appeared as double bands, again indicating the
potential of giantin to form a dimer. Overall, the data suggest selectivity of BFA to different Golgi
matrix proteins and imply that giantin can exist in its dimeric form only when localized to the Golgi.
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3.2. Examination of Giantin-Giantin Interaction by Proximity Ligation Assay
To validate this observation, we performed the quantitative in situ proximity ligation assay (PLA),
which detects very close proximity between two proteins (below 40 nm) [72]; PLA is largely used to
detect protein dimerization [73–75]. Briefly, cells were labeled with primary antibodies from different
species that are specific for the two target domains. Then, secondary antibodies conjugated with
the short oligonucleotides were added. These oligonucleotides were used to generate circular DNA,
which was then amplified and tagged with a red fluorescence dye. Following DAPI staining of the
nuclei, the cells were examined by confocal fluorescence microscopy. Thus, epitopes that are within 40
nm of each other are detected as a red fluorescent spot. Here, we employed two different antibodies
to giantin: mouse monoclonal, which recognizes the cytoplasmic N-terminus (3–91 aa), and rabbit
polyclonal, which is raised against the central region (1781–1907 aa). If giantin is considered as an
extended Golgi protein with the cytoplasmic rod of ~250 nm [45], then we should not be able to
detect PLA signal in control cells, since the target epitopes reside within the distance much larger than
required 40 nm. However, to our surprise, we were able to detect PLA signal in control (DMSO-treated)
cells (Figure 2A,B), suggesting that the N-terminal of giantin can bend due to flexibility in its central
non-coiled coil regions (predicted by UniProtKB–Q14789). Thus, the cytoplasmic domain of giantin
dimer is rather hooked than floppy rod-like (Figure 2C). We believe that the detected fluorescence
reflects the PLA signal from both parallel chains of giantin dimer, including the potential crosslinking
between 3–91 aa domain from one chain and 1781–1907 aa domain from another. Conversely, the PLA
signal in BFA-treated cells was negligible compared to the control cells, implying that de-dimerization
of giantin associates with extension of its cytoplasmic domain (Figure 2A–C). However, when we
performed PLA using antibodies raised against epitopes localized in the distal N-terminus within
40 nm (same mouse anti-giantin 3–91 aa described above and rabbit polyclonal anti-giantin 108–157
aa), strong PLA signal was detected in both DMSO- and BFA-treated cells (Figure S3). Predictably, in
control cells, fluorescent punctae were localized in perinuclear area, while in BFA-treated cell they
were predominantly distributed at the cell periphery. Moreover, fluorescence intensity was reduced
after BFA, again indicating that the part of the PLA signal in control cells can be attributed to the
crosslinking interaction between the chains of giantin dimer.
3.3. AFM Characterization of Giantin Protein
To visualize the monomerization of giantin in BFA-treated cells, we performed the Atomic Force
Microscopy (AFM) imaging. First, we attempted to isolate endogenous giantin using anti-giantin Ab
coupled epoxy beads (Dynabeads M-450); however, after elution, IP fractions were contaminated with
the anti-giantin IgG, making interpretation of AFM images difficult. Therefore, we decided to pull
down the exogenously expressed giantin, using the GOLGB1 (giantin)–pCMV6–AC–GFP construct.
Predictably, in HeLa cells, giantin-GFP localizes in the Golgi area, redistributes to the cytoplasm after
BFA treatment and returns to the Golgi after BFA-WO (Figure S4A). In addition, we selected this
strategy because giantin-GFP was successfully isolated using GFP-Trap magnetic beads (Figure S4B).
These beads consist of an anti-GFP nanobody, which represents only a single variable domain (VHH)
and can be easily separated from giantin-GFP. When we analyzed giantin-GFP by AFM, we noticed
that protein forms a large complex, particularly in DMSO-treated cells, despite the fact that the lysate
for these samples was prepared in the presence of NEM. This suggests that giantin-GFP is still able to
aggregate into a large polymeric complex and prompted us to treat samples with a low reducing agent,
2% β-mercaptoethanol. Figure 2D shows one of the typical AFM topography images of giantin protein
from BFA-treated cells obtained after deposition on the mica substrate. Proteins appear to assume
globular conformations rather than extended ones, implying the changes in native conformation after
GFP-Trap. This morphology can be clearly identified in the image as the bright spots. These bright
blobs are quite uniform exhibiting slight variation in both the height and the diameter of the globular
structures. Statistical analysis of 231 proteins resulted in <h> = 2.5 ± 0.2 nm as the height and <d> =
14.4 ± 2.9 nm as the diameter of the globular structures. Next, we used these results to estimate the
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volume of the proteins by using a “spherical cap” model, which has been successfully used in previous
AFM studies of proteins and protein-DNA complexes [76–79]. Again, the statistical histogram of those
computed protein volumes, as shown in Figure 2E has a narrow distribution, suggesting that the
stoichiometry of the protein is uniform. Fitting this histogram with Gaussian function revealed two
main peaks with maxima at 194 ± 5 nm3 and 418 ± 19 nm3. The value of the second peak is doubled
compare to the first peak. Additionally, it comprises only ~10% of the entire population of the observed
proteins. We assign these peaks to the monomeric and dimeric form of the protein, respectively.Cells 2019, 8, x FOR PEER REVIEW 10 of 34 
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Next, we proceed to the analysis of giantin-GFP obtained from DMSO-treated cells. We noticed a
greater size variation of globular structures, as shown in the representative image (Figure 2F). The
appearance of small globules resembles the ones observed in BFA-treated sample, which does not
seem surprising given the presence of β-mercaptoethanol. However, along with small globules, we
observed the larger ones, indicating that in control cells giantin exists in a mixture of monomeric
and multimeric complexes. Statistical analysis of volumes for 457 proteins produced a histogram
shown in Figure 2G. Fitting this histogram with Gaussian function produced several peaks. The
first peak has the same maximum as the monomeric BFA-specific giantin at V = 198 ± 9 nm3. The
second peak has a maximum at 445 ± 21 nm3, which again is almost double the maximum of the
monomeric form. This peak comprises 27% of the total population of proteins analyzed. These results
confirm that giantin from DMSO-treated cells forms more dimer than that from cells treated with
BFA. Surprisingly, there are also larger multimers observed for both BFA- and DMSO-specific giantin.
However, while there are only a few multimers present in images of the BFA-treated sample, the
relative population of giantin-multimers is much larger in DMSO-treated samples. These results imply
that giantin can potentially form oligomeric complexes. Indeed, in the SDS-PAGE performed under
non-reducing condition, we observed in DMSO-treated samples giantin-specific band, whose size
larger than expected 800 kDa of the dimer (Figure 2H, asterisk). Notably, in BFA-treated samples, this
band was not visible, echoing the results presented in Figure 2D,E.
3.4. Giantin Dimerization Is Critical for Golgi Biogenesis
It has been suggested that giantin forms a dimer via disulfide-linked lumenal domain at
Ser3254 [44,45]. To check the critical role of this link in homodimerization of giantin and reformation of
Golgi, we constructed giantin-GFP mutant protein by substitution of the Cys3254 residue with Ser, using
the GOLGB1 (giantin)–pCMV6–AC–GFP plasmid mentioned above. Analogously to the wild-type
(WT) gaintin-GFP, giantin(-C3254S)-GFP was detected in the Golgi (Figure 3A,B) of HeLa cells. This
was anticipated given that this mutation does not interfere with the Golgi retention signal [64]. While
cells overexpressing giantin-WT-GFP were able to reform compact and perinuclear Golgi after BFA-WO,
cells transfected with mutant giantin(-C3254S)-GFP failed to do so, according to the immunostaining
with cis-Golgi GM130 and medial-Golgi MGAT1 (Figure 3C–E). Next, we performed GFP IP form the
lysates of cells overexpressing gaintin-GFP or giantin(-C3254S)-GFP and found that contrary to the
WT form, giantin lacking Cys at 3254 position does not form a dimer (Figure 3F). Altogether these
data indicate not only the critical role of this disulfide link in the dimerization of giantin but also the
leading contribution of the latter to Golgi biogenesis.
3.5. Giantin Dictates Sequential Targeting of Golgi Residential Enzymes in BFA Washout Cells
It has been suggested that, during post-BFA Golgi biogenesis, Golgi matrix proteins form a
dynamic framework for subsequent delivery of glycosylation enzymes. Accumulation of the Golgi
resident proteins in the nascent Golgi stacks was suggested to be sequential, starting from the
trans-proteins and followed by their cis-medial counterparts [80,81]. We recently found that the cis-Golgi
protein, α-1,2-mannosidase (Man-I) may use GM130-GRASP65 as the Golgi docking site, whereas
the next to Man-I enzyme in the N-glycosylation pathway, medial-Golgi glycosyltransferase MGAT1,
appeared giantin-responsive [51]. Given that GM130 and giantin reside predominantly in the cis-
and medial-Golgi, respectively [43,82,83], we analyzed in BFA-treated HeLa cells the dynamics of
colocalization of Man-I and MGAT1 with GM130 and giantin, accordingly. In untreated cells, the
vast majority of Man-I and MGAT1 immunofluorescence (IF) was detected in the Golgi (Figure 4A,B).
BFA-induced Golgi dissolution is accompanied by significant segregation of Man-I and MGAT1 from
GM130 and giantin, respectively (Figure 4A,B); however, we should admit that the minor colocalization
of resident enzymes with Golgi matrix proteins was always detectable after BFA. In the meantime, in
BFA-WO cells, Man-I, but not MGAT1, was detected in recovered Golgi membranes, but the restoration
of MGAT1′s intra-Golgi signal occurred only after complete recovery of the Golgi (Figure 4A,B,E). This
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MGAT1-related phenomenon was validated using GM130 as an alternative marker of Golgi membranes
(Figure S5). Next, to better evaluate the distribution of golgins and resident proteins in reforming
Golgi membranes, we decided to employ structured illumination superresolution microscopy (SIM)
to create 3D reconstructed images with a lateral resolution (~110 nm) approximately twice that of
diffraction-limited instruments. The calculated Pearson coefficient of colocalization confirmed that,
contrary to Man-I, MGAT1 was segregated from the emerging Golgi membranes (Figure 4C,D,F and
Movies S3 and S4).
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Figure 3. The disulfide bond in the luminal domain of giantin is critical for its dimerization and Golgi
biogenesis. (A,B) Confocal immunofluorescence images of Golgi in HeLa cells transfected with WT
giantin tagged with GFP at the C-terminus or with the same construct mutated at Cys3254 to Ser. Cells
were stained with GM130 to validate localization in Golgi. (C,D) Immunostaining of MGAT1 (C) or
GM130 (D) in HeLa cells overexpressing giantin-WT-GFP or giantin(-C3254S)-GFP and treated with 36
µM BFA for 60 min and then WO for 60 min. Control cells were exposed to the corresponding amount
of DMSO. Images were captured using the EVOS M5000 Imaging System (Thermo Fisher Scientific,
Waltham, MA, USA). Nuclei counterstained with DAPI (blue); bars, 10 µm. (E) Quantification of cells
with perinuclear Golgi after BFA-WO for indicated Golgi markers; n = 90 cells from three independent
experiments. Results are expressed as a mean ± SD; * p < 0.001. (F) GFP W-B of the GFP IP isolated from
the lysates of HeLa cells transfected with giantin-WT-GFP or giantin(-C3254S)-GFP. The lysates were
prepared in the presence or absence of 2 mM NEM followed by 5% β-mercaptoethanol and resolved by
4–15% SDS-PAGE. Samples were normalized by the total protein concentration.
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Figure 4. The differential Golgi targeting mechanism for enzymes during Golgi biogenesis. (A,B)
Immunostaining of GM130 and Man-I (A), and giantin and MGAT1 (B) in HeLa cells: control
(DMSO-treated), BFA-treated, and BFA-WO for 30 min. White boxes indicate Golgi areas enlarged and
shown in three channels on the right side. Nuclei were counterstained with DAPI (blue). All confocal
images were acquired with the same imaging parameters; bars, 10 µm. (C,D) Representative 3D SIM
imaging of HeLa cells after BFA-WO. Cells were co-stained with GM130 and Man-I (C), and giantin
and MGAT1 (D). The Golgi area in the white boxes is enlarged and presented on the right side. The
orthogonal vie s of each area are shown below; bars, 10 µm. (E) I munostaining of GM130 and Man-I,
and giantin and MGAT1 in HeLa cells recovered after BFA for 60 min. (F) Quantification of Pearson’s
coefficient of colocalization for indicated proteins in cells presented in C and D; n = 15 cells for each
series of SD SIM imaging; results expressed as a mean ± SD; * p < 0.001.
These data raise the possibility that giantin-sensitive enzymes may populate Golgi at the latest
stages of Golgi biogenesis. To find the definitive argument to support this concept, we performed the
series of PLA. Using a combination of Abs ((a) mouse anti-MGAT1 and rabbit anti-giantin; and (b)
mouse anti-GM130 and rabbit anti-Man-I), we detected a strong PLA signal in control cells, which
was significantly reduced after BFA treatment (Figure 5A,B), echoing the results presented in Figure 4.
However, after 30 min of BFA recovery, PLA fluorescence was recovered only in cells exposed to
GM130 + Man-I Abs (Figure 5A,B), again confirming the physical closeness of these proteins (but not
MGAT1 and giantin) in emerging Golgi membranes.
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Figure 5. Interaction of MGAT1 and giantin. (A) PLA in HeLa cells treated with DMSO, BFA, and
BFA-WO. The proximity of MGAT1 and giantin was evaluated using mouse anti-MGAT1 and rabbit
anti-giantin Abs. The closeness of GM130 and Man-I was examined using mouse anti-GM130 and
rabbit anti-Man-I Abs. Red punctae indicate PLA signal, nucleus is in blue, DAPI; bars, 10 µm. (B)
Quantitation of proximity ligation for indicated proteins is presented as the corrected total fluorescence
intensity (a.u.). The results are measured as a mean ± SD; * p < 0.001. (C) Bottom panel: MGAT1 W-B
of the complexes pulled down by anti-giantin Ab from the Golgi fractions isolated from HeLa cells:
control, and recovered at 30 and 60 min of BFA-WO. The input of giantin is presented at the top panel.
The IP using control rabbit IgG served as a control. (D) Giantin W-B of the lysate or the complex pulled
down from the lysates of non-treated HeLa cells using biotinylated hMGAT1 N-terminal peptide and
Dynabeads M-280 Streptavidin. Control samples are the Dynabeads incubated with cell lysate in the
presence (+) or absence (−) of control peptide. (E) MGAT1 W-B of the complexes pulled down from the
lysate of non-treated HeLa cells using giantin-GST N-terminal peptide immobilized by anti-GST Ab
coupled epoxy beads. The anti-GST beads exposed to the cell lysate only and IP using control rabbit IgG
are the control. (F) The proposed model of Golgi targeting. Enzymes that employ GM130-GRASP65
docking site are able to reach membranes during Golgi biogenesis, contrary to other Golgi resident
proteins that use giantin. The targeting of the latter occurs after giantin dimerization and complete
restoration of Golgi morphology.
While we have shown previously that in cells depleted from giantin, MGAT1 was mislocalized
to the ER [51], we have not yet clarified whether MGAT1 directly interacts with giantin. Here,
we performed several experiments to explore the potential mechanism of MGAT’s docking at the
giantin-specific Golgi site. First, we detected that giantin Ab was able to pull-down MGAT1 from the
Golgi fraction of control HeLa cells (Figure 5C). In the meantime, an only marginal fraction of MGAT1
was pulled down in cells recovered for 30 min after BFA-WO; however, after 60 min of recovery, when
compact Golgi appears in most of the cells (Figure 4E), the fraction of giantin-associated MGAT1
was significantly higher (Figure 5C). This finding implies that the short cytoplasmic tail of MGAT1
directly interacts with giantin. Previously, to evaluate the interaction of Golgi residential proteins with
non-muscle Myosin IIA (NMIIA), we employed the N-terminal biotinylated peptides representing the
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cytoplasmic tail of different glycosyltransferases [29,65]. Peptides were linked to magnetic Dynabeads
followed by incubation with lysate. Here, we used the same tool to examine whether endogenous
giantin interacts with a biotin-MLKKQS peptide (GenicBio BioTech, China) that matches N-terminus
of MGAT1. The control peptide biotin-GHGTGSTGSGSMLRTLLRRRL (LifeTein LLC, South Plainfield,
NJ, USA) incubated with lysate and Dynabeads, as well as the lysate incubated with Dynabeads
only served as a control. As shown in Figure 5D, Dynabeads carrying MGAT1 peptide were able to
pull-down giantin from the lysate of HeLa cells, however, giantin was not detected in the pull-down
fraction from the lysate exposed to the Dynabeads or in combination with control peptide.
Since we observed the positive PLA signal using mouse polyclonal anti-MGAT1 (immunogen -
full-length protein, corresponding to 1–445 aa of human MGAT1) and rabbit polyclonal anti-giantin
108–157 aa (Figure 5A), it is logical to hypothesize that the MGAT1 binding domain of giantin lies within
its N-terminal non-coiled-coil area (UniProtKB-Q14789). To examine this plausibility, we employed
the recombinant human N-terminal GST-giantin fusion peptide (3–92 aa, Abcam). This peptide is
successfully immobilized by anti-GST Ab coupled epoxy beads (Dynabeads M-450), according to the
GST Western blot (W-B) (data not shown). Then, the beads containing giantin-GST was incubated
(overnight, at 4 ◦C) with the cell lysate of non-treated HeLa cells. The anti-GST Ab coupled epoxy
beads incubated with lysate only, as well as the IP by the non-specific IgG Ab coupled epoxy beads
were served as a control. W-B analysis of the lysate and pull-down fractions revealed that substantial
amounts of endogenous MGAT1 were pulled down by giantin-containing beads, but not by beads
alone or control IgG-coupled beads (Figure 5E). Altogether, data in Figure 5A–E indicate that the
cytoplasmic tail of MGAT1 is able to interact directly with the N-terminal of giantin.
We found another proof of differential Golgi targeting of O-glycosylation enzymes in PCa cells.
As we described previously, Golgi transportation of C2GnT-L requires giantin and intact Golgi
morphology, whereas Golgi-directed trafficking of the Core 1 synthase (C1GalT1, cis-Golgi) and
β-galactoside α-2,3-sialyltransferase-1 (ST3Gal1, medial-trans-Golgi) is GM130-GRASP65-dependent
and does not require a compact Golgi structure [34]. In non-treated, low passage LNCaP (c-28) cells, all
three enzymes were localized to the Golgi, and, predictably, BFA treatment resulted in their relocation
to the ER (Figure S6A). In BFA-WO cells, both C1GalT1 and ST3Gal1 were returned to the membranes
as soon as Golgi reformed back. However, the pool of C2GnT-L on the recovered Golgi was very faint
(Figure S6A,B), resembling the results of MGAT1 in HeLa cells (Figure 4). Thus, it seems that the
delayed Golgi targeting of MGAT1 and C2GnT-L is associated with incomplete giantin dimerization
and Golgi reconstruction. These data suggest that the genesis of Golgi architecture and enrichment
of resident proteins do not necessarily coexist simultaneously. Rather, we propose a simple model
illustrating that giantin-sensitive N- and O-glycosylation enzymes are packaged in their appropriate
site only within a compact and perinuclear Golgi (Figure 5F).
3.6. Giantin, but not Other Golgi Proteins, Is the Main Driver of Golgi Biogenesis
These findings led us to the question of whether giantin is the critical protein in the formation of
juxtanuclear Golgi. To answer this, we performed in HeLa cells two series of the individual siRNAs
(containing the pools of three to five target-specific siRNAs) depletion of giantin, GM130, and GRASP65,
followed by treatment with BFA and its WO. We found that KD of GM130 or GRASP65 does not alter
Golgi reassembly; however, in cells lacking giantin, Golgi remains disorganized, even though multiple
Golgi fragments intend to concentrate around the nucleus (Figure 6A,B,D). Quantitatively, depletion
of giantin results in almost complete loss of ability to restore compact and perinuclear Golgi, but,
in GM130- or GRASP65-depleted cells, the number of cells which failed to recover Golgi was only
marginal and identical to control (Figure 6C). To validate the universality of this screen, we repeated
the same experiment in Panc-1 (Figure S7A,D), A549 (Figure S7B,E), and LNCaP (c-28) (Figure S7C,F)
cell lines derived from different organs and confirmed that post-BFA restoration of compact Golgi is
governed by giantin, but not by GM130-GRASP65 complex.
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Figure 6. Giantin is necessary for the restoration of compact Golgi upon BFA washout. (A,B) Confocal
immunofluorescence images of Golgi were collected in HeLa cells pretreated with different siRNAs
for 72 h followed by exposure to 36 µM BFA for 60 min and then WO for 30 min. The combination
of GRASP65 + giantin immunostaining was used for cells treated with scramble or giantin siRNAs,
and giantin + GM130 and GRASP65 + GM130 were used for cells treated with GM130 and GRASP65
siRNAs, respectively. Images in the white boxes are enlarged and displayed as either green or red
channels on the right side. Nuclei counterstained with DAPI (blue); bars, 10 µm. (C) Quantification
of cells with perinuclear Golgi, as shown in (A,B); n = 90 cells from three independent experiments
of giantin, GM130, and GRASP65 KD performed with two different combinations of target-specific
siRNAs. Results are expressed as a mean ± SD; * p < 0.001. (D) Giantin, GM130, and GRASP65 W-B of
lysates of HeLa cells treated with the corresponding siRNAs (I and II); β-actin was a loading control.
It is known that depletion of different Golgi proteins, including GRASP55 [30], GCC88 [84],
Golgin-97 [85], Golgin-245 (or p230) [86], GCC185 [87], and TMF [88], may affect the Golgi ribbon
and induce central Golgi fragmentation, but it has no significant effect on the perinuclear position
of Golgi. To check whether any of these proteins are involved in the fusion of Golgi membranes,
we performed individual siRNA-mediated depletion of their genes and monitored reconstruction of
Golgi in cells recovered after 30 and 60 min of BFA-WO. While KD of GRASP55 induces moderate
unstacking of Golgi membranes, it does not prevent Golgi recovery after BFA-WO (Figure S8A–C). In
cells lacking either GCC88 (Figure S9A–C) or Golgin-97 (Figure S10A–C), Golgi undergoes marginal
enlargement, but it does not block post-BFA reformation of perinuclear Golgi. Similarly, despite the
obvious but minimal changes in Golgi morphology after KD of Golgin-245 (Figure S11A–C), GCC185
(Figure S12A–C) or TMF (Figure S13A–C), cells lacking any of these golgins do not lose the ability to
reconnect Golgi membranes in juxtanuclear space. Importantly, none of these proteins is required for
BFA-induced Golgi collapse because the effect of this drug in golgin- or GRASP55-depleted cells was
identical to cells treated with control siRNAs (Figure S8–S13).
Next, we proceeded to check the role of Rab GTPases in Golgi biogenesis, since these enzymes
are required for the SNARE-mediated fusion of membranes [89]. Out of 70 human Rab GTPases, 20
proteins show Golgi localization [90] but, to the best of our knowledge, only Rab1a, Rab6a, Rab18,
and Rab41 may interfere with Golgi morphology [34,91,92]. While Rab1a and Rab18 demonstrate
predominantly perinuclear localization (Figures S14A and S15A, accordingly), the distribution of Rab41
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was detected in both cytoplasm and Golgi (Figure S16A). The depletion of either Rab1, Rab18, or Rab41
has no effect on the perinuclear situation of Golgi, but, in Rab1a KD cells, we were able to detect mild
enlargement of Golgi membranes. However, none of these GTPases is required for restoration of Golgi
after BFA-WO (Figures S14B,C, S15B,C, and S16B,C). Based on these results, we decided to focus on
the possible role of Rab6a in interconnection of Golgi membranes.
3.7. The Mutuality of Rab6a and Giantin
Others and we have shown that retrograde Golgi-to-ER transportation of glycosyltransferases
is mediated by the interaction of their cytoplasmic tail with NMIIA, and it is coordinated by the
function of Rab6a [8,29,65,93–95]. We recently observed that giantin and NMIIA may compete for
Rab6a. In cells treated with EtOH, giantin de-dimerization was accompanied by the loss of its link
to Rab6a. In the meantime, we observed the enhanced complex between Rab6a and NMIIA, which
creates a force for Golgi disassembly [95]. Importantly, Rab6a was required for post-alcohol recovery
of Golgi in hepatocytes [55]. We also reported that in PC-3 and DU145 cells, Golgi morphology appears
disorganized, however, treatment with NMIIA inhibitor Blebbistatin or transfection with NMIIA
siRNAs converts fragmented Golgi to the compact structure [34]; this Golgi “metamorphosis” was
also conducted by Rab6a. Finally, it has been shown that Rab6A and giantin directly interact via their
N-terminus [96]; however, the link between giantin and Rab6a in Golgi biogenesis has never been
explored. Here, we examined the interaction of Rab6a and giantin, using again the model of post-BFA
“Golgi renaissance”. First, in LNCaP cells after 30 min of BFA-WO, we detected less NMIIA but more
giantin associated with Rab6a than in cells right after 60 min treatment with BFA (Figure 7A). Second,
we confirmed this observation by detecting colocalization of Rab6a with giantin but not NMIIA in the
partially reconstructed Golgi of LNCaP cells after BFA-WO (Figure 7B,C). Third, when we performed
life cell imaging of BFA-WO HeLa cells that co-expressed giantin-GFP and Rab6a-RFP, the multiple
giantin-Rab6a colocalizing punctae was seen in restored perinuclear structures (Movie S5).
To validate these screens, we implemented the proof-of-principle experiment, using cell-free
reconstitution of Golgi membranes [97]. First, we isolated Golgi membranes from non-treated and
BFA-treated HeLa cells according to the protocol established previously [29]. As shown in Figure 7D,
the remnants of the Golgi membranes from BFA-treated samples contain giantin, but not Rab6a. Thus,
we used these samples to study the effect of exogenous Rab6a on the fusion of the nascent Golgi
membranes. Briefly, the 500 µL of Golgi membranes isolated from BFA-treated HeLa cells were exposed
to 5 µg of active Rab6a protein (Abcam) in the presence of the cytosolic fraction and the Reaction Mix,
which includes 20 µL of 0.5 M EDTA, 10 µL of 100× GTPγS (Cell Biolabs), and 2 µL of ATP (Energy)
Regeneration Solution (Enzo). The suspension was incubated in 37 ◦C water bath for 15 min. Then,
the reaction was stopped by 65 µL of 1 M MgCl2. Another sample of Golgi membranes was prepared
analogously, except the addition of active Rab6a protein. Rab proteins require prenylation for insertion
into membranes. Herein, we detected that, under such conditions, Rab6a protein was prenylated, since
it was detected in the detergent fraction after Triton X-114 phase partitioning (data not shown) [98].
Next, samples were incubated with anti-giantin Ab followed by Alexa Fluor 488 secondary Ab (1 h at
RT for each step). Then, samples were gently transferred to the slides, air-dried under the hood in
dark, and covered by the glass slips using ProLong antifade mountant (Thermo Scientific). Finally, we
reconstructed 3D volume-rendered surfaces from the SIM imaging of Golgi membranes and evaluated
the luminal length of these membranes by the ImageJ software. In the samples lacking Rab6a, the
largest segregated Golgi structures did not exceed 2 µm; however, the length of Golgi membranes
that have been fused in presence of Rab6a was significantly increased and very close to the values we
saw in the Golgi fraction from non-treated cells (Figure 7E,F). These data strongly indicate that the
maturation of Golgi membranes and their fusion are mediated by the function of Rab6a. Indeed, in
another series of 3D SIM imaging of BFA-WO HeLa cells, endogenous Rab6a and giantin were found
in the close vicinity (Figure 7G, top panel). Remarkably, in many reconstructed Golgi surfaces, we
detected Rab6a punctae between the two emerging giantin-stained membranes (Figure 7G, bottom
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panel). To further check this hypothesis, we performed the PLA experiment using mouse anti-giantin
and rabbit anti-Rab6a Abs. In control cells, we detected only a moderate PLA signal. It does not seem
surprising, because contrary to medial-Golgi giantin [43,82,83], Rab6a is preferentially distributed in
the trans-Golgi, where is involved in different intra-Golgi events [98–101]. No physical closeness of
Raba and giantin was detected in BFA-treated cells, again confirming the segregation of Rab6a from
the BFA-induced Golgi remnants (Figure 7D). However, PLA punctae were identified after as early as
30 min of BFA-WO (Figure 7H,I), indicating that the strong interaction between Rab6a and giantin is
detectable only in the fused Golgi membranes.Cells 2019, 8, x FOR PEER REVIEW 18 of 34 
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BFA for 60 min and then 30 min WO. Amounts of lysates used for IP were normalized to giantin
or NMIIA, as described in S ction 2. Non-specific rabbit IgG was used for control IP. Red and blue
markers indicate BFA and BFA-WO samples, respectively. (B) Confocal immunofluorescence images of
Rab6a colocalization with giantin and NMIIA in LNCaP BFA-WO cells. (C) Quantification of Pearson’s
overlap coefficient for indicated pairs of stained proteins in cells after BFA-WO. All confocal images
were acquired with the same imaging parameters; bars, 10 µm. Data collected from 90 cells of three
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of the postnuclear supernatant (PNS) and Golgi membranes collected from the HeLa cells: control and
treated with BFA. (E) The representative 3D reconstruction of the SIM imaging of Golgi membranes
isolated from HeLa cells: non-treated, and treated with BFA followed by incubation with or without
Rab6a protein. The regenerated Golgi membranes were stained with giantin; bars, 2 µm. (F)
Quantification of the average length of Golgi membranes (n = 30 from each sample) presented in (E).
(G) Top panel: the reconstructed 3D SIM imaging of Golgi in HeLa cells after 30 min of BFA-WO.
Cells were stained with Rab6a (green) and giantin (red). The representative area of Golgi is presented
in the bottom panel. Note the Rab6a punctae between giantin-positive emerging Golgi membranes.
(H) PLA in HeLa cells treated with DMSO, BFA, and BFA-WO. The proximity of giantin and Rab6a
was evaluated using mouse anti-giantin and rabbit anti-Rab6a Abs. Red punctae indicate PLA signal,
nucleus is in blue, DAPI; bars, 10 µm. (I) Quantitation of proximity ligation for Rab6a and giantin is
presented as the corrected total fluorescence intensity (a.u.). The results are measured as a mean ± SD; *
p < 0.001.
These data prompted us to check whether a mutual link exists between Rab6a and giantin,
i.e., whether localization of Rab6a to the Golgi is impaired in giantin-depleted cells recovering after
BFA treatment, and, conversely, whether fusion of Golgi membranes is impaired in cells lacking
Rab6a. In cells treated with scramble siRNAs, after 60 min of BFA-WO, the IF signal of Rab6a was
predominantly compact and perinuclear. A similar distribution of Rab6a was observed in GM130- or
GRASP65-depleted cells recovered from BFA; however, in cells transfected with giantin siRNAs, after
60 min of BFA-WO, Rab6a was equally distributed throughout the cell (Figure 8A). Quantification
of Rab6a IF associated with membranous structures indicated that giantin KD, but not GM130 or
GRASP65 KD, blocks the recollection of Rab6a into the Golgi membranes (Figure 8B). Next, in cells
treated with scramble siRNAs, after 60 min of BFA-WO, the distribution of giantin IF signal was closed
to the non-treated cells (Figure 8C,D,F). At the same time, cells transfected with Rab6a siRNAs failed to
recover Golgi, according to the staining with either giantin (Figure 8D–F) or GM130 (Figure S16). The
similar results were obtained in cells transfected with dominant-negative (GDP-bound) Rab6a(T27N),
confirming that Golgi cisternal maturation requires GTPase activity of Rab6a (Figure 8D,F and Figure
S17). In sum, these data clearly indicate that Rab6a is required for the stabilization of dimeric structure
of giantin and Golgi reformation.
3.8. Is GRASP65 the Protein that May Compensate for the Lack of Giantin?
The alternative to the giantin Golgi docking site is represented by GM130, a segmented coiled-coil
dimer of which the C-terminal region binds to Golgi membranes preferentially through interaction
with GRASP65 [43,102–104]. However, our previous results indicate that in the absence of GRASP65,
GM130 may form a complex with giantin [34,43]. Given that, in cells lacking both giantin and GRASP65,
the intra-Golgi signal of GM130 is compromised [43], it is logical to assume the existence of a reserved
Golgi tethering mechanism for GM130, one that in absence of GRASP65 can be realized through a direct
link between giantin and GM130. Our results thus far suggest that giantin is essential for the biogenesis
of Golgi in terms of its compact structure and perinuclear localization. However, in giantin-depleted
cells, GM130- and GRASP65-specific immunostainings do not seem significantly different from
the cells transfected with control siRNAs, at least at the level of conventional multi-fluorescence
microscopy [13,54,105]. This suggests that cells that are not under the treatment with Golgi disturbing
agents but are experiencing a deficiency in giantin may launch a compensatory mechanism to maintain
Golgi positioning and function. Among Golgi proteins, GRASP65 and GRASP55 are the only two that
form stable homodimers to further oligomerize in trans-form [106–108]. It has been proposed that this
structural feature of GRASPs is essential to hold adjacent Golgi membranes in stacks: GRASP65 for the
cis-Golgi, and GRASP55 for the medial-trans-cisternae [35,109]. Remarkably, the siRNA-mediated KD
of GRASP65 increases the level of giantin [43]. However, it is important to note here that the response
of GRASP55 to ER stress differs from GRASP65 [110–112], and thus far no virtual link between giantin
and GRASP55 is reported, raising the possibility that at the level of cis-medial-Golgi, functions of giantin
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and GM130-GRASP65 (but not giantin and GRASP55) may overlap, allowing mutual compensation.
In HeLa cells, giantin depletion increases the content of GRASP65; however, the densitometric ratio
monomer/dimer was identical to control cells. In the meantime, the level of GRASP65 tetramer was
significantly enhanced (Figure 9A,B). We reasoned that giantin, and GRASP65 in absence of giantin,
serve as the scaffold for Golgi intercisternal connections that seem necessary to maintain not only Golgi
stacking but also rapid trafficking and processing [113–115]. Indeed, when we performed co-depletion
of both giantin and GRASP65, Golgi perinuclear positioning and organization were substantially
impaired (Figure 9C–E).
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Figure 8. The overlap of giantin and Rab6a during Golgi biogenesis. (A) Confocal immunofluorescence
images of Rab6a in HeLa cells after 60 min of BFA-WO, pretreated with scramble, giantin, GM130,
or GRASP65 siRNAs. All confocal images acquired with the same imaging parameters; bars, 10 µm.
(B) Quantification of cells with membranous Rab6a in cells presented in (A); n = 90 cells from three
independent experiments, results are expressed as a mean± SD; * p < 0.001. (C) Giantin immunostaining
in DMSO- and BFA-treated HeLa cells. (D) Giantin immunostaining in HeLa cells after 60 min of
BFA-WO, transfected with scramble, Rab6a siRNAs, and dominant-negative (GDP-bound) Rab6a(T27N).
(E) Rab6a W-B of lysates of HeLa cells treated with corresponding siRNAs; β-actin was a loading
control. (F) Quantifications of cells with perinuclear Golgi in cells from (C,D); n = 90 cells from three
independent xpe i ents, results expressed as a mean ± SD; *, p < 0.001.
Thus, cells lacking detectable giantin appear to possess Golgi stacks and perinuclear location
due to GRASP65 oligomerization. However, several cardinal differences came to our attention after
thorough ultrastructural analysis of Golgi performed by a series of 3D SIM imaging. First, the average
total length of contiguous Golgi cisternae decreased to 1.509 ± 0.609 µm in giantin-KD cells, from
15.12 ± 4.597 µm in control cells. The same phenomenon was detected in prostate cell lines: RWPE-1
and LNCaP (data not shown). Second, a distance of intercisternal connections was significantly
reduced: the “long” communications in control cells (1.509 ± 0.6090 µm) after giantin depletion were
replaced by the “short bridges” (280 ± 204 nm) (Figure 9F,G). Finally, the number of cisterna-to-cisterna
communications per Golgi stack was also lower in cells lacking giantin (4.6 ± 1.578) compared to control
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cells (8.7 ± 1.636). Kernel density plots calculated for each variable revealed significant differences in
the location and shape of the distributions by group (Figure S18). Next, the visualization of described
differences was combined in an ellipsoid at the XYZ plot (Figure 9H). These results suggest that giantin
appears to be critical for the maintenance of Golgi cisternae continuity and their connections.
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Figure 9. Differential Golgi phenotype in control and giantin-depleted cells. (A) GRASP65 W-B of
the lysate of HeLa cells: treated with a scramble and giantin siRNAs; β-actin was a loading control.
Longer exposure for GRASP65-tetramer is presented in the top panel. (B) Quantification of the intensity
of bands corresponding to GRASP65: monomer/dimer and tetramer/dimer. Calculations performed
within the same exposure, and data represent mean ± SD from three independent experiments; * p <
0.001. (C) Confocal immunofluorescence images of GRASP65 and Golgin-97 or giantin and Golgin-97
in HeLa cells treated with scramble or a mix of GRASP65 and giantin siRNAs; bars, 10 µm. (D)
Quantifications of cells with perinuclear Golgi in cells from C; n = 90 cells from three independent
experiments, results expressed as a mean ± SD; * p < 0.001. (E) Giantin and GRASP65 W-B of the
HeLa cells treated with scramble or mix of GRASP65 and giantin siRNAs; β-actin was a loading
control. (F,G) 3D SIM imaging of giantin and GRASP65 in HeLa cells transfected with a scramble
and giantin siRNAs, respectively; bars, 1 µm. Red lines indicate the size of intercisternal connections.
The representative area of intercisternal connections is highlighted by white boxes and presented on
the right side. (H) Statistical analysis of cisternal length, size of intercisternal connections, and their
number. Clear separation of observations in control and giantin KD HeLa cells visualized in an XYZ
plot where mean and SD were calculated for each parameter (axis) and then used to display an ellipsoid
for both conditions. The large ellipsoid represents control data, the small ellipsoid represents giantin
KD. Contour (shadow) of ellipsoids presented at Z = 0. Hypothesis testing for different medians was
performed via non-parametric Wilcoxon rank-sum test. p-values for length of cisternae, intercisternal
distance, and number of connections are 2.2544 × 10−29, 1.2278 × 10−16, 5.2380 × 10−4, respectively,
with Wilcoxon.
4. Discussion
The ability of the Golgi apparatus to recover after severe attacks is unique and could play a
significant role in cellular homeostasis. Here, we describe the role of the largest golgin giantin in
the maintenance of Golgi stability and the dynamics of its membranes. We show that BFA-induced
Golgi disorganization is associated with the loss of giantin dimeric structure. At first glance, it seems
hard to imagine how a long dimer could unwind quickly. However, we are not the first to describe
such kind of phenomenon. For example, several coiled-coil proteins, including golgin GCC185,
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may unwind in several domains [116,117]. In addition, some dimeric myosin motor proteins may
exist in their monomeric form [118]. In addition, the induction of ER stress by the Arf1 mutant
results in the relocation of GRASP55 dimer to the ER and its subsequent monomerization [111].
Notably, in different cells and organs, EtOH-induced Golgi disorganization was associated with giantin
de-dimerization [13,52]. In our preliminary screening, treatment of prostate cells with the ER stress
inducer, Thapsigargin, results in Golgi fragmentation, which again was accompanied by the loss of
giantin dimer (manuscript in preparation). Highly aggressive PCa cells, PC-3 and DU145, which are
experiencing ER stress under normal conditions, demonstrate fragmented Golgi phenotype and lack of
giantin dimer [34]. Thus, it is attempting to speculate that link between giantin monomerization and
Golgi disorganization can be attributed to not only the BFA-induced cellular perturbations but also to
the other clinically relevant cases of ER stress. This assumption still requires rigorous investigations.
We have shown that giantin C-terminal is critical not only for its Golgi retention but also for its
dimerization and Golgi reassembly. We would not exclude the potential contribution of the coiled-coil
domain of giantin to the fusion of Golgi membranes. In our preliminary screening, we observed
that giantin (C3254S) construct with additional potentially critical point mutation in the coiled-coil
domain (Glu1978Lys) still able to reside in the perinuclear space and recover Golgi after BFA (data not
presented). However, the precise role of coiled-coil domains in the stabilization of giantin dimer still
remains uncovered. Our results are echoing previous observation of Warren’s group [104]; however,
they do not fit completely with the publication of Misumi et al. [64], who showed that truncated
giantin mutant lacking C-terminal transmembrane domain (2619–3162aa) is not only able to reach the
Golgi in HeLa cells but also does not block post-BFA Golgi reassembly. Since this giantin peptide
lacks a disulfide-bonded lumenal domain, it seems conflicting with the data presented in our story.
However, these authors used low dosage (7 µM) and short time (30 min) treatment of BFA. Using
different combinations of BFA dosage and timing, we noticed that treatment of HeLa cells with 36 µM
BFA for 1 h was necessary to induce complete redistribution of giantin IF signal to the cytoplasm, when
cells already exhibit no perinuclear Golgi elements, but does not undergo apoptosis yet. Thus, we
prefer the model of Golgi collapse, as described by Perez group, when giantin is “transported back to
the ER in the presence of BFA as the Golgi ‘blinks out’” [119]. Quite contrarily, in their figures, Misumi
et al. presented BFA-treated cells that still demonstrate predominant disposition of giantin punctae in
the perinuclear area.
Our results clearly indicate that Golgi biogenesis requires giantin, and this finding harmonizes
well with recently published data by Stevenson et al. that the recovery of Golgi after BFA was abolished
in the giantin KO model [54]. While we observed the reduction of cisternal length in cells lacking
giantin, these authors could not detect significant changes in this Golgi parameter. Moreover, another
publication by Satoh et al. [120] observed that loss of giantin elongates Golgi cisternae, contradicting
their own previous observation [50]. There are several explanations for this discrepancy. First, given
that individual Golgi cisternae are complex structures that are extensively interconnected, we used
3D reconstructed images of Golgi, while authors of these two publications analyzed the mean length
of cisternae from separate Z-stacks obtained by electron microscopy (EM). Second, the conclusion of
these groups was based on the calculations for all Golgi cisternae, including trans-Golgi and elongated
membranes of the trans-Golgi network. Instead, we are focused on the cis-medial-Golgi, where GRASP65
and giantin mostly reside. Finally, the difference between our data and results from Satoh et al. can
be partially ascribed to the variety of sizes found in HeLa cells. Indeed, using the EM technique,
two different groups presented contradicting results regarding the effect of double knockdown of
GRASP65/55 on unstacking of Golgi in HeLa cells [109,121].
Here, we found that the reformation of Golgi membranes also depends on the activity Rab6a
GTPases. The appearance of Rab6a in the Golgi coincides with giantin dimerization and Golgi
reconstitution. At this point, we may assume the existence of at least two events that require the virtual
involvement of giantin. First, during clustering to the perinuclear region, giantin monomers from the
rims of opposite cisternae form the dimer via disulfide bond in the luminal domain. Then, giantin’s
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and Rab6a’s N-terminus tether to each other, thus forming dual giantin-Rab6a dimeric complexes
(Figure 10); given the ability of Rab6a to dimerize [95,122], this scenario seems realistic. This, in turn,
stabilizes giantin dimer via the formation of a coiled-coil structure. We believe that this is the critical
step in the fusion of Golgi membranes because cells lacking Rab6a or its GTPase activity are unable
to recollect Golgi membranes in the perinuclear space. Second, giantin seems indispensable for the
formation of a communication between Golgi stacks. Our results also indicate that, in addition to the
dimeric form, giantin may exist as an oligomer (Figure 2). The nature of this phenomenon remains
unknown and could be subject to future studies that could also address the question of whether giantin
oligomeric complexes are essential for the formation of large cisterna-cisterna communications. While
the function of these internal Golgi “bridges” remains elusive, it was suggested that they could play
a role in intra-Golgi trafficking and maintenance of the compact shape of the Golgi [113–115]. The
alternative “short” intercisternal communications provided by GRASP65 oligomers seems efficient for
Golgi compaction and positioning, but not sufficient for proper processing, because giantin depletion
cardinally changes rate and quality of glycosylation, at least in HeLa cells [50]. It is important to note
here that, in normal cells, giantin depletion itself does not lead to the loss of Golgi centralization,
because the gradual decline in giantin expression can be compensated by the oligomerization of
GRASP65. However, giantin appears to be critical for the recovered cells that attempt to restore Golgi
architecture after different stresses.Cells 2019, 8, x FOR PEER REVIEW 24 of 34 
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structure. Such fusion requires the force presumably created by the action of F-actin based motor
protein, non-muscle Myosin IIB.
It is known that cells pretreated with NMIIA siRNA or its inhibitor Blebbistatin demonstrate a
significant delay in BFA-induced Golgi disorganization [65,123]. We have also shown that NMIIA
is tethered to Golgi membranes under different drug and stress conditions, such as treatment with
EtOH, heat shock, or inhibition of heat shock proteins (HSPs), and depletion of the beta-COP
subunit of COPI [8,29,95]. Thus, it seems that NMIIA is a master regulator of ER stress mediated
Golgi disorganization. However, we recently found that post-alcohol recovery of compact Golgi
in hepatocytes is blocked in cells depleted from non-muscle Myosin IIB (NMIIB), the isoform of
NMIIA [55]. Our preliminary data (data not shown) indicate that NMIIB is also required for post-BFA
Golgi recovery, implying that intercisternal fusion requires a force that can be created by the action of
NMIIB. Although there exists no direct evidence as to how NMIIB is tethered to the Golgi, our data
make this a likely scenario.
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The relationship between the matrix and resident Golgi proteins is increasingly viewed as a
mutual alliance, where the function of some may influence the behavior of others [30,31,43,94,124,125].
On the one hand, golgins and GRASPs are able to form a Golgi matrix framework regardless of
the presence of Golgi enzymes [71]. On the other hand, Golgi appears as a disassembled structure
when some glycosyltransferases fail to localize to the Golgi [126–128]. For example, a mutation in
the membrane-spanning domain of an N-acetylglucosaminyltransferase I caused a dramatic effect
on Golgi morphology [129]. In CHO cells lacking N-acetylglucosaminyltransferase V (MGAT5), the
Golgi volume density was significantly reduced [130]; however, this was not ascribed to the lack of
enzymatic function, given that in the absence (or inhibition) of its precursors, MGAT1 and Mann-II,
the Golgi seems unaffected. However, we do not rule out that this possibility may be limited only to
the glycosyltransferases that form complexes with cytoskeletal proteins [131–133]. It is important to
note, however, that the cytoplasmic tail of Golgi enzymes plays an essential role not only in their Golgi
retention but that it also mediates tethering of NMIIA to the Golgi membranes, thus providing the force
for alcohol- or BFA-induced Golgi disorganization [29,65,95,133,134]. Here, we provide the evidence
which indicates that the cytoplasmic domain of MGAT1 is also required for the Golgi targeting. Since
the N-terminal of giantin is projecting into the cytoplasm, it is clear that the direct interaction between
MGAT1 and giantin occurs outside of the Golgi lumen. However, we still do not know whether
giantin, in addition to the docking function, can also serve as a Golgi retention partner for MGAT1.
This possibility requires further investigation.
Our results confirm that the response of giantin to rapid ER stress is distinct from that of GM130
and GRASP65: while some golgins (including Golgin-45 and giantin) and GRASP55 can be partially
detected in the ER, both GM130 and GRASP65 are still retained in the Golgi remnants [110–112].
Moreover, we observed that BFA treatment does not impair the oligomerization of these proteins
and provided evidence that the function of the GM130-GRASP65 complex is not critical for the Golgi
recovery. This may explain why GM130-GRASP65-dependent enzymes are able to quickly refill
emerging Golgi membranes. Our model suggests that giantin dimerization is a necessity for successful
Golgi biogenesis. Since the formation of giantin-dimer requires functional COPII [51] and, broadly
speaking, the dynamic of Golgi membranes is linked to the integrity of ER exit site [36,135], we believe
that any substantial disturbance of ER function would inevitably result in Golgi dysfunction and its
subsequent disorganization.
We show here that in cells lacking giantin, GRASP65 oligomerization may take a leading role
in Golgi remodeling and maintenance of its positioning. However, GRASP65 consistently fails to
form oligomers in different PCa cells with fragmented Golgi phenotype (our manuscript, in press).
We would not exclude the possibility that cancer-specific Golgi fragmentation [136–140] is influenced
by the dysfunction of ER, because multiple studies observed the virtual link between ER stress and
cancer [141]. Therefore, prolonged but sub-lethal ER stress may lead to not only impairment of giantin
dimerization, but also to alteration of posttranslational modification of GRASPs and other golgins [142].
In this case, the consequences of Golgi disintegration will appear more severe than one induced by
the deficiency in giantin dimerization after treatment with BFA. Lastly, most golgins and GRASPs
have multiple potential N- or O-glycosylation sites, and in the case of giantin, this was preliminary
confirmed [34], suggesting their posttranslational modification may require the assistance of Golgi
enzymes. Thus, it is reasonable to conclude that full maturation of Golgi matrix proteins occurs
after the appearance of all resident enzymes at the Golgi membranes and complete Golgi recovery.
For example, in parasitic protozoan Giardia lamblia, Golgi was not identified in nonencysting cells;
nevertheless, the induction of Golgi enzyme activities coincides with the stacking of Golgi during
differentiation to cysts [143]. Therefore, our model requires that some of the proteins (which Golgi
targeting likely requires giantin) prefer to hold the occupation of membranes until complete recovery of
Golgi (Figure 5F). The appearance of MGAT1 in the reformed Golgi membranes coincides with giantin
dimerization, which prompts us to speculate that the binding site of giantin for MGAT1 becomes
available only after giantin dimerization. This assumption requires further experimental support.
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In some aspects, this conception does not fit with the idea that enzymes refill membranes during
Golgi biogenesis according to their intra-Golgi (from trans to cis) location [80,81]. However, given
that early forming structures in Golgi assembly are inactive in cargo transport [81], the holdup of
giantin-sensitive enzymes seem reasonable, because, in this scenario, the accomplishment of Golgi
recovery would coincide with the commencement of protein glycosylation.
If one assumes that, in mammalian cells, compact and perinuclear Golgi is essential for complete
glycosylation, does it follow that any disturbance in Golgi morphology will result in the abnormal
glycan processing of cargo? The answer lies in the comparison of BFA with other Golgi disruptive
agents, such as Cytochalasin D or Nocodazole. Indeed, destabilization of actin by Cytochalasin D [144]
or alteration of microtubules after Nocodazole [145] results in extensive Golgi fragmentation [29].
Nevertheless, in these cells, the giantin-dependent enzyme, for instance, C2GnT-M, still localizes in
the Golgi [29], suggesting that these chemicals have no significant effect on the structure or function
of giantin. This could explain the abnormal glycosylation in BFA-treated cells [146,147] that is not
found in cells incubated with either Cytochalasin D or Nocodazole [30,148]. Therefore, while Golgi
is anchored in juxtanuclear space inter alia by cooperation with cytoskeleton proteins, successful
glycosylation is determined by the intra-Golgi location of residential enzymes rather than by the
positioning of Golgi [149,150]. The important question of how these separated “mini-Golgi”, induced
by either Nocodazole or Cytochalasin D, communicate to maintain glycosylation of cargo remains to
be answered. At first glance, clues may come from the vesicular Golgi model rather than a cisternal
maturation conception; however, we are still far from a complete understanding of the nature of the
many COPI- and COPII-independent vesicular and tubular complexes that have been detected in the
Golgi [43,65,151–153]. One of the promising arsenals for these studies is high-resolution microscopy,
without which accomplishment of the current story would have been impossible.
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